Anpario Plc

Anpario Plc

ANP · LSE · Consumer Defensive / Packaged Foods

515.00GBX+2.00 (+0.39%)

Price History

Full chart

Market Stats

Previous Close513.00
Open515.00
Day Range515.00 – 520.00
52-Week Range384.73 – 570.55
Volume4.74K
Market Cap83.66M
P/E (TTM)13.21
Forward P/E11.64
EPS0.39
Dividend Yield2.44%
Beta1.08
50-Day Avg512.94
200-Day Avg515.28

About

Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands. It also provides water sanitation tablets, an insect control powders and natural drying agents under the Red Lite, Credence, Mitex, and Clean & Dry brands; and toxin management category products consisting of mycotoxin binders under the Anpro brand. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Richard Peter Edwards B Eng (Hons), B.E., C Eng, M.B.A.
  • Employees162
  • HeadquartersManton Wood Enterprise Park, Worksop, United Kingdom, S80 2RS, UK
  • Websitehttps://www.anpario.com

Leadership

  • Mr. Richard Peter Edwards B Eng (Hons), B.E., C Eng, M.B.A.Executive Vice Chairman & CEO · b. 1965
  • Mr. Marc Charles Wilson A.C.M.A., B.A.Group Finance Director & Director · b. 1988
  • Ms. Karen Lesley Prior B.Sc., B.Sc. (Hons), F.C.A.Corporate Responsibility Director, Company Secretary & Director · b. 1960
  • Mr. Shane BaileyOperations Director
  • Ms. Sarah Osborne BSc. HonsCorporate Development Director

Financials

Income Statement

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue334.00K180.00K217.00K159.00K422.00K5.35M5.43M10.96M21.57M19.20M23.51M25.95M23.45M23.32M24.34M29.24M28.28M29.05M30.52M33.37M33.10M31.00M38.20M47.17M
Growth (%)--46.11%+20.56%-26.73%+165.41%+1168.25%+1.42%+101.82%+96.85%-10.98%+22.46%+10.38%-9.64%-0.54%+4.36%+20.14%-3.30%+2.72%+5.08%+9.32%-0.79%-6.36%+23.22%+23.51%
Cost of Revenue235.00K132.00K149.00K330.00K307.00K3.60M3.53M7.82M15.62M13.44M15.85M16.88M13.95M12.85M12.89M14.89M14.73M15.16M15.32M17.84M19.61M17.04M20.28M23.80M
Gross Profit99.00K48.00K68.00K-171.00K115.00K1.75M1.90M3.13M5.95M5.75M7.66M9.07M9.50M10.47M11.45M14.35M13.54M13.88M15.20M15.53M13.49M13.96M17.34M23.37M
Gross Margin29.64%26.67%31.34%-107.55%27.25%32.77%34.95%28.59%27.58%29.98%32.58%34.97%40.50%44.89%47.02%49.06%47.89%47.79%49.79%46.54%40.75%45.03%45.40%49.54%
Operating Expense1.30M565.00K446.00K470.00K473.00K1.34M1.47M1.75M4.49M3.97M6.07M6.14M6.45M6.92M7.80M10.36M9.07M9.23M9.93M9.88M9.88M11.44M12.45M15.48M
Operating Income-1.20M-517.00K-378.00K-641.00K-358.00K416.00K429.00K1.38M1.46M1.79M1.59M2.93M3.05M3.55M3.64M3.99M4.47M4.65M5.27M5.65M3.61M2.52M4.89M7.89M
Operating Margin-358.98%-287.22%-174.19%-403.14%-84.83%7.77%7.90%12.58%6.77%9.31%6.78%11.29%13.00%15.24%14.96%13.64%15.82%16.00%17.27%16.93%10.89%8.14%12.81%16.72%
EBITDA-999.00K-510.00K-367.00K-632.00K-338.00K457.00K436.00K816.00K1.65M2.18M3.75M3.23M3.39M3.95M3.24M4.23M5.55M5.54M6.59M6.98M4.91M4.00M6.38M9.33M
EBITDA Margin-299.10%-283.33%-169.12%-397.48%-80.09%8.54%8.03%7.45%7.67%11.33%15.97%12.44%14.46%16.94%13.31%14.46%19.63%19.08%21.58%20.91%14.83%12.89%16.71%19.78%
Net Income-1.17M-510.00K-346.00K-602.00K-287.00K336.00K336.00K1.21M1.28M1.67M2.10M2.56M3.16M3.74M2.58M2.98M4.00M3.71M4.21M4.68M3.30M2.53M4.11M6.75M
Net Income Margin-349.70%-283.33%-159.45%-378.62%-68.01%6.28%6.19%11.05%5.94%8.68%8.95%9.85%13.48%16.02%10.60%10.21%14.15%12.79%13.78%14.03%9.98%8.16%10.77%14.31%
R&D100.00K33.00K58.00K25.00K32.00K21.00K37.00K75.00K51.00K46.00K751.00K62.00K40.00K198.00K587.00K121.00K110.00K23.00K43.00K42.00K98.00K63.00K215.00K224.00K
R&D as % of Total Revenue29.94%18.33%26.73%15.72%7.58%0.39%0.68%0.68%0.24%0.24%3.19%0.24%0.17%0.85%2.41%0.41%0.39%0.08%0.14%0.13%0.30%0.20%0.56%0.47%
Interest Expense370.00K2.00K2.00K0058.00K130.00K1.00K296.00K351.00K2.38M78.00K21.00K0005.00K9.00K5.00K4.00K3.00K6.00K4.00K12.00K
Interest Expense % of Total Revenue110.78%1.11%0.92%0.00%0.00%1.08%2.39%0.01%1.37%1.83%10.15%0.30%0.09%0.00%0.00%0.00%0.02%0.03%0.02%0.01%0.01%0.02%0.01%0.03%

Balance Sheet

Currency: GBP2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets173.00K742.00K599.00K439.00K861.00K2.01M8.48M8.95M8.67M18.65M19.93M20.20M24.41M26.13M29.06M31.49M34.05M37.20M38.20M40.42M44.48M47.98M48.53M40.19M47.15M50.49M
Total Liabilities362.00K445.00K614.00K500.00K242.00K146.00K1.72M1.82M1.14M5.05M5.14M4.20M6.52M6.00M6.32M4.90M5.51M6.68M5.05M4.87M6.97M7.68M7.22M6.54M10.85M9.53M
Total Equity-297.00K-15.00K-61.00K619.00K1.86M6.76M7.13M7.54M13.56M14.74M15.95M17.89M20.13M22.75M26.58M28.54M30.52M33.15M35.55M37.51M40.30M41.31M33.65M36.29M40.96M
Cash2.00K332.00K66.00K42.00K477.00K1.78M1.35M1.67M1.87M5.01M3.53M4.36M3.69M4.78M6.63M9.34M11.11M13.56M12.91M13.84M15.82M13.74M11.74M10.54M10.50M12.41M
Total Debt---------30.00K3.00K-------198.00K188.00K90.00K85.00K52.00K79.00K74.00K244.00K
Net Debt---66.00K-42.00K-477.00K-1.78M-1.35M-1.67M-1.87M-4.99M-3.53M-4.36M-3.69M-4.78M-6.63M-9.34M-11.11M-13.56M-12.71M-13.65M-15.73M-13.66M-11.69M-10.46M-10.43M-12.16M

Cash Flow

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.12M-487.00K-481.00K-541.00K-1.67M651.00K432.00K2.08M1.01M2.02M2.17M2.92M3.25M3.39M3.80M5.23M2.69M3.97M5.83M3.15M1.09M8.70M5.84M6.02M
Investing Cash Flow-4.00K-3.00K39.00K-3.96M-332.00K-230.00K-3.37M-2.26M-636.00K-2.50M-1.25M-781.00K-306.00K-1.50M-1.20M-1.85M-1.42M-1.17M-1.36M-1.56M1.21M-4.18M-1.62M
Financing Cash Flow856.00K463.00K914.00K1.81M5.19M--4.43M-237.00K-523.00K-323.00K-512.00K-615.00K-328.00K-649.00K-1.53M-1.46M-1.57M-2.52M-2.01M-1.96M-10.96M-1.54M-2.28M
Capital Expenditure4.00K04.00K04.03M380.00K283.00K270.00K2.33M686.00K283.00K470.00K289.00K301.00K729.00K151.00K695.00K1.67M1.26M1.42M1.54M743.00K1.94M566.00K
Free Cash Flow-1.12M-487.00K-485.00K-541.00K-5.70M271.00K149.00K1.81M-1.31M1.33M1.89M2.45M2.96M3.09M3.07M5.08M1.99M2.30M4.57M1.72M-453.00K7.95M4.20M5.46M
Dividends Paid-------101.00K210.00K361.00K436.00K568.00K677.00K911.00K1.02M1.58M1.43M1.57M1.73M2.02M2.19M1.76M1.83M2.06M
FCF to OCF100.36%100.00%100.83%100.00%341.75%41.63%34.49%87.02%-129.49%65.96%86.96%83.92%91.10%91.13%80.81%97.12%74.15%57.96%78.46%54.75%-41.67%91.45%71.85%90.60%
Dividend Paid to FCF-------5.58%-15.99%27.16%23.11%23.16%22.89%29.45%33.37%31.08%71.82%68.14%37.80%117.48%-482.56%22.16%43.57%37.68%

Earnings

Report DateApr 14, 2014May 17, 2016Sep 14, 2016Mar 8, 2017Sep 19, 2017Mar 6, 2018Sep 17, 2018Mar 6, 2019Sep 11, 2019Mar 18, 2020Sep 9, 2020Mar 15, 2021Sep 15, 2021Mar 16, 2022Sep 14, 2022Mar 22, 2023May 19, 2025Sep 9, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.00-0.00----0.00-
EPS Actual0.070.090.060.060.080.070.090.100.090.090.090.110.080.130.100.050.140.16
Surprise------------------
Timing-------------Pre-marketPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap83.66M
Enterprise Value68.90M
Trailing P/E13.21
Forward P/E11.64
PEG Ratio0.00
Price / Sales1.72
Price / Book1.89
EPS0.39
Book Value2.52
Revenue (TTM)48.75M
Gross Profit (TTM)24.58M
EBITDA9.50M
Profit Margin14.53%
Operating Margin15.18%
Return on Equity17.45%
Return on Assets10.54%
Shares Outstanding16.24M
Shares Float14.30M
Beta1.08
Dividend Yield2.44%
Dividend Rate0.13
Payout Ratio29.40%

Dividends

20262×
0.04Nov 12, 20260.09Jul 9, 2026
20252×
0.04Nov 13, 20250.08Jul 10, 2025
20242×
0.03Nov 14, 20240.07Jul 11, 2024
20232×
0.03Nov 9, 20230.07Jul 13, 2023
20222×
0.03Nov 10, 20220.07Jul 14, 2022
20212×
0.03Nov 11, 20210.06Jul 15, 2021
20202×
0.03Nov 12, 20200.06Jul 16, 2020
20192×
0.03Nov 14, 20190.05Jul 11, 2019
20182×
0.02Nov 15, 20180.04Jul 12, 2018
20172×
0.02Nov 16, 20170.06Jul 13, 2017
20161×
0.05Jul 14, 2016
20151×
0.04Jul 16, 2015
20141×
0.04Jul 9, 2014
20131×
0.03Jul 3, 2013

Stock Splits

  • Oct 4, 20101:23